These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17303014)

  • 1. High-grade T1 bladder cancer at the ureterovesical junction.
    Soloway M
    Curr Urol Rep; 2007 Mar; 8(2):104-7. PubMed ID: 17303014
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 60-year-old man with gross hematuria and flank pain.
    Miller ET; Aronson WJ; Bassett JC
    Urology; 2014 Jun; 83(6):1233-5. PubMed ID: 24231218
    [No Abstract]   [Full Text] [Related]  

  • 4. Transurethral partial cystectomy with continuous wave laser for bladder carcinoma.
    Yang Y; Wei ZT; Zhang X; Hong BF; Guo G
    J Urol; 2009 Jul; 182(1):66-9. PubMed ID: 19450852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical cystectomy--often too late? 1987.
    Stockle M; Alken P; Engelmann U; Jacobi GH; Riedmiller H; Hohenfellner R
    Eur Urol; 2006 Dec; 50(6):1132-8. PubMed ID: 17183625
    [No Abstract]   [Full Text] [Related]  

  • 7. Radical cystectomy for bladder cancer: morbidity of laparoscopic versus open surgery.
    Guillotreau J; Gamé X; Mouzin M; Doumerc N; Mallet R; Sallusto F; Malavaud B; Rischmann P
    J Urol; 2009 Feb; 181(2):554-9; discussion 559. PubMed ID: 19084856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade transitional cell carcinoma of the pediatric bladder.
    Korrect GS; Minevich EA; Sivan B
    J Pediatr Urol; 2012 Jun; 8(3):e36-8. PubMed ID: 22105002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous cell carcinoma and transitional cell carcinoma arising in bladder augmentations.
    Woolsey S; Nambirajan T; Mahendra V; Mulholland C; Kernohan R
    Scand J Urol Nephrol; 2003; 37(3):269-70. PubMed ID: 12775289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of early-invasive high-grade transitional cell carcinoma of the bladder.
    Fritsche HM; Burger M
    Minerva Urol Nefrol; 2008 Dec; 60(4):265-71. PubMed ID: 18923363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive T1 bladder cancer: indications and rationale for radical cystectomy.
    Stein JP; Penson DF
    BJU Int; 2008 Aug; 102(3):270-5. PubMed ID: 18494831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.
    Rouprêt M; Seisen T; Compérat E; Larré S; Mazerolles C; Gobet F; Fetissof F; Fromont G; Safsaf A; d'Arcier BF; Celhay O; Validire P; Rozet F; Irani J; Soulié M; Pfister C;
    J Urol; 2013 Jun; 189(6):2069-76. PubMed ID: 23201497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Guérin.
    Günlüsoy B; Değirmenci T; Arslan M; Nergiz N; Minareci S; Ayder AR
    Urol Int; 2005; 75(2):107-13. PubMed ID: 16123562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy.
    Masood S; Mufti GR
    Urology; 2008 Oct; 72(4):952; author reply 952. PubMed ID: 18926256
    [No Abstract]   [Full Text] [Related]  

  • 15. Some pitfalls in pathological staging of invasive urothelial carcinoma.
    MacLennan GT; Taylor JM
    J Urol; 2004 Oct; 172(4 Pt 1):1464. PubMed ID: 15371871
    [No Abstract]   [Full Text] [Related]  

  • 16. Life-threatening hematuria due to recurrent arterial-conduit fistula.
    Hori S; Thiruchelvam N
    Urology; 2012 Jan; 79(1):23-7. PubMed ID: 22000929
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of high-risk non-muscle invasive bladder cancer.
    Brausi M; Olaru V
    Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
    Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
    BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of p53 nuclear overexpression in patients of muscle invasive urinary bladder carcinoma treated with cystectomy.
    Hemal AK; Khaitan A; Dinda AK; Gupta NP; Seth A; Dogra PN; Nabi G
    Urol Int; 2003; 70(1):42-6. PubMed ID: 12566814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
    Thrasher JB; Frazier HA; Robertson JE; Dodge RK; Paulson DF
    Cancer; 1994 Mar; 73(6):1708-15. PubMed ID: 8156499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.